Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-034878

Director sold 5,000 shares at $39.79 ($198,950)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DOBMEIER ERIC Director 2020-06-03 Option exercise +5,000 $6.32 $31,600 5,000 D: show line 1 in the form
DOBMEIER ERIC Director 2020-06-03 Sale −5,000 $39.79 $198,950 0 D: show line 2 in the form
Open-market sales · 5,000 sh · avg $39.79 · $198,950

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
DOBMEIER ERIC Director 2020-06-03 Option exercise · Stock Option (Right to Buy) −5,000 65,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…